News in the Life Sciences Industry

COPENHAGEN, Denmark, Sept. 17, 2020 /PRNewswire/ -- IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune-modulating anti-cancer therapies based on its proprietary T-win® technology, today announced a late-breaking, oral presentation of best-in-class efficacy data in... Read more ››

ABBOTT PARK, Ill., Sept. 17, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) is introducing the world's first glucose sport biosensor,(i) Libre Sense Glucose Sport Biosensor, which is designed for athletes to continuously measure glucose to better understand the correlation between their glucose levels... Read more ››

HEIDENHEIM, Germany, Sept. 17, 2020 /PRNewswire/ -- Together with the "World Day for Patient Safety" of the World Health Organization (WHO), today HARTMANN is launching its initiative to reduce the risk of healthcare-related infection - Mission: Infection Prevention (M: IP). The company is... Read more ››

Supply Agreement will continue into 2021

BAD HOMBURG, Germany, Sept. 17, 2020 /PRNewswire/ -- MYR Pharmaceuticals, a German biotechnology company focused on the development and commercialization of therapeutics for the treatment of chronic hepatitis B and D, is pleased to announce that HEPCLUDEX(®) (bulevirtide) has successfully launched... Read more ››

OSAKA, Japan and FORT WORTH, Texas, Sept. 16, 2020 /PRNewswire/ -- Santen Pharmaceutical Co., Ltd. (hereinafter "Santen") and Eyevance Holdings LLC announced that Santen Holdings U.S. Inc., a wholly-owned subsidiary of Santen, and Eyevance Holdings LLC entered into a share purchase agreement... Read more ››

MUNICH, VIENNA and DENVER, Sept. 16, 2020 /PRNewswire/ -- TLL The Longevity Labs GmbH (Longevity Labs+), an Austrian-based life sciences company, and its wholly-owned, US subsidiary, Longevity Labs Inc., are proud to announce their award for "The Most Innovative OTC-Product" at the German 2020... Read more ››

WOBURN, Mass., Sept. 15, 2020 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer... Read more ››

SHANGHAI and BERLIN and MINNEAPOLIS, Sept. 15, 2020 /PRNewswire/ -- Eyesafe, UnitedHealthcare Vision and TÜV Rheinland Group today announced the dates and registration details as well as the initial lineup of companies and thought leaders participating in the Read more ››

WOBURN, Massachusetts, Sept. 14, 2020 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapy, SIR-Spheres® Y-90 resin microspheres, is pleased to report that positive trial data from the NASIR-HCC Study was reported by Professor Bruno Sangro at the... Read more ››

WOBURN, Mass., Sept. 14, 2020 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapy, SIR-Spheres® Y-90 resin microspheres, is pleased to report that positive trial data from the NASIR-HCC Study was reported by Professor Bruno Sangro at the International... Read more ››

This press release is intended for trade and medical press journalists only. This press release is NOT intended for consumer press journalists.